NCT00153543View on ClinicalTrials.gov

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

PCV7 + PPV23, 2 months

BIOLOGICAL

PCV7 + PPV23, 6 months

Trial Locations (1)

99508

Alaska Native Medical Center, Anchorage

All Listed Sponsors
collaborator

Alaska Native Tribal Health Consortium

OTHER

collaborator

Southcentral Foundation

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00153543 - Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders | Biotech Hunter | Biotech Hunter